All News #Library
Biotech
Shorla Gets FDA Orphan Tag for SH-110 Brain Cancer Drug
15 Jul 2025 //
BUSINESSWIRE
Shorla & EVERSANA Announce U.S. Commercial Launch of FDA-Approved JYLAMVO
19 Dec 2023 //
PR NEWSWIRE
Shorla Oncology & EVERSANA Announce Launch of Recent FDA-Approved Nelarabine Inj
16 May 2023 //
PR NEWSWIRE

Market Place
Sourcing Support